Two Sigma Securities’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,769
Closed -$212K 1905
2025
Q2
$212K Buy
+18,769
New +$203K 0.03% 890
2024
Q4
Sell
-15,778
Closed -$182K 2937
2024
Q3
$182K Buy
+15,778
New +$180K ﹤0.01% 2181
2023
Q4
Sell
-13,532
Closed -$158K 3498
2023
Q3
$158K Buy
+13,532
New +$153K ﹤0.01% 2342

Other funds holding ROIV

Two Sigma Securities's ROIV Position: Q3 2025 in Review

Two Sigma Securities sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 18,769 shares — an estimated $212K sold.

Two Sigma Securities first reported a position in ROIV in Q3 2023 and held it in 3 quarters. The position peaked at $212K in Q2 2025. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Two Sigma Securities reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 18,769 Roivant Sciences shares in Q3 2025, an estimated $212K.
  • Two Sigma Securities first reported a position in Roivant Sciences in Q3 2023 and held it in 3 quarters.
  • Two Sigma Securities's Roivant Sciences position peaked at $212K in Q2 2025.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.